Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 9:11:45-51.
doi: 10.2147/DMSO.S156597. eCollection 2018.

Protein-induced satiation and the calcium-sensing receptor

Affiliations
Review

Protein-induced satiation and the calcium-sensing receptor

Utkarsh Ojha. Diabetes Metab Syndr Obes. .

Abstract

Obesity is a major global health issue. High-protein diets have been shown to be associated with weight loss and satiety. The precise mechanism by which protein-rich diets promote weight loss remains unclear. Evidence suggests amino acids, formed as a consequence of protein digestion, are sensed by specific receptors on L-cells in the gastrointestinal (GI) tract. These L-cells respond by secreting gut hormones that subsequently induce satiety. In recent years, the calcium-sensing receptor has been identified in several cells of the GI tract, including L-cells, and suggested to sense specific amino acids. This review evaluates the evidence for protein-rich diets in inducing weight loss and how the calcium-sensing receptor may be implicated in this phenomenon. Commandeering the mechanisms by which elements of a protein-rich diet suppress appetite may provide another successful avenue for developing anti-obesity drugs.

Keywords: amino acids; energy regulation; glucagon-like-peptide-1; obesity therapy; peptide YY.

PubMed Disclaimer

Conflict of interest statement

Disclosure Utkarsh Ojha is a medical student at Imperial College London holding a Medical Sciences BSc in Endocrinology. The author reports no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Gut–brain axis: consequence of amino acid sensing by receptors on the EEC. Notes: Following sensing of amino acids by receptors on the EEC, peptides such as GLP-1 and PYY are secreted from the EEC and regulate food intake by binding to their respective receptors. PYY binds to Y2R located on the vagus nerve fiber terminals, which signals to the brain stem and eventually the hypothalamus. GLP-1 can pass through the blood and act directly at GLP-1 receptors in the hypothalamus and exert its effects on satiety. The hypothalamus has a collection of nuclei (not shown in Figure 1); the ARC is a collection of neurons in the mediobasal hypothalamus, and is thought to be implicated in the control of food intake. The ARC contains two populations of neurons with opposing effect on food intake. The agouti-related peptide/neuropeptide Y neurons stimulate food intake, whereas pro-opiomelanocortin neurons suppress appetite. The ARC also sends numerous projections to both extra- and intra-hypothalamic regions responsible for energy homeostasis, including the paraventricular nucleus. Further connections are formed between these populations of neurons and higher brain centers. Abbreviations: ARC, arcuate nucleus; CaSR, calcium-sensing receptor; EEC, enteroendocrine cells; GLP-1, glucagon-like peptide-1; GPRC6A, G-protein-coupled receptor family C group 6-member A; PYY, peptide tyrosine tyrosine; T1R, taste receptor 1; Y2R, Y2 receptors.

Similar articles

Cited by

References

    1. World Health Organization WHO: Obesity and Overweight. [Accessed April 23, 2017]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
    1. World Health Organization WHO: The Top 10 Causes of Death. [Accessed April 23, 2017]. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/
    1. National Institute for Health and Care Excellence . Obesity: Identification, Assessment and Management. London: National Institute for Health and Care Excellence; 2014.
    1. Pontiroli A, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–487. - PubMed
    1. Christensen R, Kristensen P, Bartels E, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet. 2007;370(9600):1706–1713. - PubMed

LinkOut - more resources